Recommends confirming acromegaly in patients with elevated or equivocal IGF-1 by demonstrating lack of GH suppression to <1 µg/L after an oral glucose load. Triggers include equivocal IGF-1 results requiring diagnostic certainty before proceeding to imaging.
Scanned 9/9/2026
Install to Claude Code
npx -y skills add dromlakhani/MD2SKILL --skill endo-confirm-gh-suppression-ogtt --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Endo Confirm Gh Suppression Ogtt?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-endo-confirm-gh-suppression-ogtt)More formats (shields.io, HTML) on the badges page.
---
name: endo-confirm-gh-suppression-ogtt
description: Recommends confirming acromegaly in patients with elevated or equivocal IGF-1 by demonstrating lack of GH suppression to <1 µg/L after an oral glucose load. Triggers include equivocal IGF-1 results requiring diagnostic certainty before proceeding to imaging.
---
# Confirm acromegaly with GH suppression after OGTT
## STEP 1 — Gather Information
Obtain serum IGF-1; if elevated or equivocal, proceed to an oral glucose tolerance test (OGTT) with 75 g glucose after an overnight fast, measuring plasma glucose and GH at baseline and intervals (e.g., 0, 30, 60, 90, 120 min) to confirm hyperglycemia and assess GH suppression.
## STEP 2 — Rule In / Rule Out
Is the nadir GH concentration after OGTT <1 µg/L? If yes, rule out acromegaly (sufficient suppression); if no (GH ≥1 µg/L), rule in acromegaly (lack of suppression).
## STEP 3 — Classify or Stratify
Classify as confirmed acromegaly when GH is not suppressed (GH ≥1 µg/L) and IGF-1 is elevated or equivocal; otherwise consider alternative diagnoses or repeat testing.
## STEP 4 — Decide
If acromegaly is confirmed, refer for pituitary MRI to evaluate tumor size and extent; if not confirmed, repeat IGF-1 evaluation and consider other causes of IGF-1 alteration.
## Clinical Guardrails / Mimics / Pitfalls
Ensure documented hyperglycemia during OGTT to validate the test; avoid relying on random GH measurements; be aware of assay limitations at low GH levels and conditions that may cause false‑positive GH nonsuppression (e.g., malnutrition, renal failure, hypothyroidism).
## Concrete Clinical Example
A 48‑year‑old patient with progressive shoe‑size enlargement and borderline elevated IGF‑1 undergoes a 75‑g OGTT; glucose peaks at 210 mg/dL and nadir GH is 1.4 µg/L. Lack of suppression confirms acromegaly, prompting pituitary MRI which reveals a 12‑mm macroadenoma.
**Source:** Acromegaly: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2700
> **TODO:** consider adding scripts/calc.py for the endo-confirm-gh-suppression-ogtt calculator
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!